Title |
Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media
|
---|---|
Published in |
Cochrane database of systematic reviews, December 2013
|
DOI | 10.1002/14651858.cd004975.pub3 |
Pubmed ID | |
Authors |
Sanguansak Thanaviratananich, Malinee Laopaiboon, Patravoot Vatanasapt |
Abstract |
Acute otitis media (AOM) is a common problem in children, for which amoxicillin, with or without clavulanate, is frequently prescribed as a treatment of choice. The conventional recommendation is either three or four daily doses. However, nowadays it is frequently prescribed as once or twice daily doses. If once or twice daily amoxicillin, with or without clavulanate, is as effective for acute otitis media as three or four times a day, it may be more convenient to give the medication once or twice a day to children and hence improve compliance. |
X Demographics
The data shown below were collected from the profiles of 53 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 18 | 34% |
Chile | 2 | 4% |
Japan | 2 | 4% |
United Kingdom | 1 | 2% |
Ecuador | 1 | 2% |
France | 1 | 2% |
Saudi Arabia | 1 | 2% |
Netherlands | 1 | 2% |
Colombia | 1 | 2% |
Other | 1 | 2% |
Unknown | 24 | 45% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 46 | 87% |
Practitioners (doctors, other healthcare professionals) | 4 | 8% |
Science communicators (journalists, bloggers, editors) | 1 | 2% |
Scientists | 1 | 2% |
Unknown | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Chile | 1 | <1% |
United States | 1 | <1% |
Ecuador | 1 | <1% |
Unknown | 152 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 24 | 15% |
Other | 15 | 10% |
Student > Master | 14 | 9% |
Student > Bachelor | 14 | 9% |
Student > Postgraduate | 10 | 6% |
Other | 36 | 23% |
Unknown | 42 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 58 | 37% |
Nursing and Health Professions | 12 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
Agricultural and Biological Sciences | 5 | 3% |
Psychology | 4 | 3% |
Other | 17 | 11% |
Unknown | 50 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 42. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2023.
All research outputs
#899,366
of 23,905,714 outputs
Outputs from Cochrane database of systematic reviews
#1,904
of 12,768 outputs
Outputs of similar age
#10,136
of 314,094 outputs
Outputs of similar age from Cochrane database of systematic reviews
#38
of 222 outputs
Altmetric has tracked 23,905,714 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,768 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.7. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,094 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 222 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.